PURPOSE: We determined whether genetic variability in the gene encoding for tumor necrosis factor-alpha (TNF-alpha) contributes to individual differences in susceptibility to the development of preeclampsia. METHODS: The study involved 133 preeclamptic and 115 healthy control pregnant women who were genotyped for C-850T polymorphism in the TNF-alpha gene promoter. Chi-square analysis was used to assess genotype and allele frequency differences between preeclamptic women and controls. RESULTS: A significantly different genotype distribution of C-850T polymorphism was observed between the two groups, with the frequency of the variant T allele being significantly reduced in the preeclamptic group (4.5%) when compared with the control group (9.6%) (P = 0.03; OR = 0.45, 95% CI = 0.22-0.92). Accordingly, the odds ratio for preeclampsia associated with the pooled TT and CT genotypes was 0.367 (P = 0.02; 95% CI = 0.159-0.847). CONCLUSIONS: The T allele of the TNF-alpha gene may modify individual preeclampsia risk, being protective against the development of the complication.
PURPOSE: We determined whether genetic variability in the gene encoding for tumor necrosis factor-alpha (TNF-alpha) contributes to individual differences in susceptibility to the development of preeclampsia. METHODS: The study involved 133 preeclamptic and 115 healthy control pregnant women who were genotyped for C-850T polymorphism in the TNF-alpha gene promoter. Chi-square analysis was used to assess genotype and allele frequency differences between preeclamptic women and controls. RESULTS: A significantly different genotype distribution of C-850T polymorphism was observed between the two groups, with the frequency of the variant T allele being significantly reduced in the preeclamptic group (4.5%) when compared with the control group (9.6%) (P = 0.03; OR = 0.45, 95% CI = 0.22-0.92). Accordingly, the odds ratio for preeclampsia associated with the pooled TT and CT genotypes was 0.367 (P = 0.02; 95% CI = 0.159-0.847). CONCLUSIONS: The T allele of the TNF-alpha gene may modify individual preeclampsia risk, being protective against the development of the complication.
Authors: K Ward; A Hata; X Jeunemaitre; C Helin; L Nelson; C Namikawa; P F Farrington; M Ogasawara; K Suzumori; S Tomoda Journal: Nat Genet Date: 1993-05 Impact factor: 38.330
Authors: B K Rinehart; D A Terrone; S Lagoo-Deenadayalan; W H Barber; E A Hale; J N Martin; W A Bennett Journal: Am J Obstet Gynecol Date: 1999-10 Impact factor: 8.661
Authors: J C Livingston; V Park; J R Barton; S Elfering; B Haddad; W C Mabie; M Quasney; B M Sibai Journal: Am J Obstet Gynecol Date: 2001-05 Impact factor: 8.661
Authors: Eliza C Miller; Ashley Wilczek; Natalie A Bello; Sarah Tom; Ronald Wapner; Yousin Suh Journal: Ageing Res Rev Date: 2021-12-03 Impact factor: 10.895